Procainamide Hydrochloride (Hospira, Inc.)


Welcome to the PulseAid listing for the Procainamide Hydrochloride drug offered from Hospira, Inc.. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: PROCAINAMIDE HYDROCHLORIDE
SUBSTANCE NAME: PROCAINAMIDE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2006-03-08
END MARKETING DATE: 0000-00-00


Procainamide Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProcainamide Hydrochloride from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2006-03-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1902_57fd8c16-b3b2-466e-98ea-2c2ca12da21c
PRODUCT NDC: 0409-1902
APPLICATION NUMBER: ANDA089069

Other PROCAINAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthProcainamide Hydrochloride
Hospira, Inc.Procainamide Hydrochloride
International Medication Systems, LimitedProcainamide Hydrochloride
McKesson Packaging Services Business Unit of McKesson CorporationProcainamide Hydrochloride
Nexus Pharmaceuticals IncProcainamide Hydrochloride